263 related articles for article (PubMed ID: 2573098)
1. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
3. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
O'Brien CP; DiGiacomo JN; Webb W
Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
5. [Principles of chemotherapy of paranoid schizophrenia].
Vanelle JM; Loloum T
Encephale; 1991; 17(4):235-40. PubMed ID: 1683623
[TBL] [Abstract][Full Text] [Related]
6. Perpetrators of homicide with schizophrenia: sociodemographic characteristics and clinical factors in the eastern region of Turkey.
Belli H; Ozcetin A; Ertem U; Tuyluoglu E; Namli M; Bayik Y; Simsek D
Compr Psychiatry; 2010; 51(2):135-41. PubMed ID: 20152293
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)].
Pietzcker A; Müller-Oerlinghausen B; Schley J; Chaskel H; Poppenberg A; Urban R
Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
[No Abstract] [Full Text] [Related]
9. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
Youssef HA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
[No Abstract] [Full Text] [Related]
10. Amoxapine as an antipsychotic: comparative study versus haloperidol.
Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
[TBL] [Abstract][Full Text] [Related]
11. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
12. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
Ozola MIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
[No Abstract] [Full Text] [Related]
13. Efficacy of haloperidol in drug refractory patients.
Ban TA; Lehmann HE
Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142
[No Abstract] [Full Text] [Related]
14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
15. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
Davis JM; Gosenfeld L; Tsai CC
Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986
[No Abstract] [Full Text] [Related]
16. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
17. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
Sheppard C; Beyel V; Fracchia J; Merlis S
Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
[TBL] [Abstract][Full Text] [Related]
18. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
Dikiĭ NT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
[TBL] [Abstract][Full Text] [Related]
19. [Sudden cessation of psychotropic drugs].
Avrutskii GIa; Gurovich IIa; Prokhorova IS; Tirkel'taub IuA; Romanov IuD
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):923-30. PubMed ID: 4156142
[No Abstract] [Full Text] [Related]
20. [Considerations on the use of long-acting neuroleptics in a mental health center].
Carotti P; Merli R
Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
